全文获取类型
收费全文 | 10662篇 |
免费 | 726篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 385篇 |
妇产科学 | 269篇 |
基础医学 | 1177篇 |
口腔科学 | 136篇 |
临床医学 | 2141篇 |
内科学 | 1712篇 |
皮肤病学 | 114篇 |
神经病学 | 1024篇 |
特种医学 | 232篇 |
外科学 | 1111篇 |
综合类 | 117篇 |
一般理论 | 27篇 |
预防医学 | 1335篇 |
眼科学 | 144篇 |
药学 | 612篇 |
中国医学 | 43篇 |
肿瘤学 | 762篇 |
出版年
2024年 | 15篇 |
2023年 | 71篇 |
2022年 | 121篇 |
2021年 | 233篇 |
2020年 | 162篇 |
2019年 | 211篇 |
2018年 | 251篇 |
2017年 | 251篇 |
2016年 | 257篇 |
2015年 | 259篇 |
2014年 | 349篇 |
2013年 | 471篇 |
2012年 | 764篇 |
2011年 | 844篇 |
2010年 | 465篇 |
2009年 | 382篇 |
2008年 | 717篇 |
2007年 | 766篇 |
2006年 | 726篇 |
2005年 | 710篇 |
2004年 | 747篇 |
2003年 | 625篇 |
2002年 | 593篇 |
2001年 | 104篇 |
2000年 | 96篇 |
1999年 | 108篇 |
1998年 | 134篇 |
1997年 | 93篇 |
1996年 | 90篇 |
1995年 | 81篇 |
1994年 | 74篇 |
1993年 | 55篇 |
1992年 | 44篇 |
1991年 | 47篇 |
1990年 | 32篇 |
1989年 | 46篇 |
1988年 | 27篇 |
1987年 | 38篇 |
1986年 | 21篇 |
1985年 | 32篇 |
1984年 | 30篇 |
1983年 | 40篇 |
1982年 | 36篇 |
1981年 | 31篇 |
1980年 | 31篇 |
1979年 | 19篇 |
1978年 | 25篇 |
1977年 | 17篇 |
1976年 | 16篇 |
1974年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Jae Sue Choi Han Suk Young Jong Cheol Park Jin-Ho Choi Won Sick Woo 《Archives of pharmacal research》1986,9(4):233-236
The flavonoids isolated from the leaves ofRhododendron brachycarpum, were identified as quercetin, avicularin, quercitrin and hyperin. 相似文献
52.
Sue Ross 《The British journal of general practice》1993,43(376):483-484
53.
Koichi Akamatsu Soichiro Miyauchi Kenji Ohshima Shunji Okita Yoshifumi Yasuhara Hiroshi Mogami Yasuyuki Ohta Ken Hamamoto 《Cancer chemotherapy and pharmacology》1989,23(Z1):S59-S64
Transcatheter arterial embolization (TAE) with the concurrent use of caerulein was assessed for the purpose of preventing gallbladder complications often seen after TAE of hepatic carcinoma. Ninety-six cases with primary hepatic carcinoma, who had undergone TAE in the right hepatic arterial region over the past 4 years, were divided into three groups: 22 cases for which embolization was possible on a selective basis by passing the catheter to the peripheral side beyond the bifurcated region of the cystic artery; 40 cases who had undergone TAE in which caerulein was not administered, from the central side of the bifurcated region of the cystic artery; and 34 cases given 20 g caerulein 15–30 min before TAE. A comparison was made using the abdominal pain, pyrexia, rate of leukocytosis and the US findings of the gallbladder as the indices of the gallbladder complications. As a result, it become evident that it was possible to prevent or alleviate gallbladder complications if caerulein were administered before TAE in cases where the embolizing substances were infused in the right hepatic artery from the central side of the bifurcated region of the cystic artery. It was conclusively shown that the gallbladder blood flow decreases if the organ is contracted by caerulein, which in turn causes a decrease in the inflow of the embolizing substances whereby complications are alleviated. 相似文献
54.
Jahrsdörfer B Wooldridge JE Blackwell SE Taylor CM Griffith TS Link BK Weiner GJ 《Journal of leukocyte biology》2005,77(3):378-387
Immunostimulatory oligodeoxynucleotides (IS ODN) can mediate a number of immunologic effects. We previously demonstrated that treatment of B cell chronic lymphocytic leukemia (B-CLL) cells with one class of IS ODN, CpG ODN, alters their phenotype and increases their immunogenicity. Here, we demonstrate that in contrast to the classic understanding of CpG ODN as inhibitors of B cell apoptosis, IS ODN including CpG ODN induce apoptosis in B-CLL cells. It is important that these changes are seen not only with CpG ODN but with ODN that lack the classical CpG motif. B-CLL cells from 20 subjects were treated in vitro with IS ODN for up to 7 days. IS ODN treatment resulted in increased numbers of apoptotic cells in 13 out of 20 B-CLL samples. IS ODN enhanced apoptosis in samples with 13q deletion as a single aberration and had a heterogeneous effect on apoptosis in samples with other aberrations including 17p deletion, 11q deletion, or trisomy 12. Induction of apoptosis did not correlate with expression of the CpG ODN receptor Toll-like receptor 9. Apoptosis was dependent on the activation of caspases and was accompanied by up-regulation of CD95/Fas and its ligand. We conclude that IS ODN including CpG ODN can induce apoptosis of most B-CLL samples. The ability of IS ODN to induce apoptosis differs based on cytogenetic status. Up-regulation of CD95/Fas may play a role in IS ODN-induced apoptosis of B-CLL. 相似文献
55.
Karen W. Gripp Lindsey A. Morse Marni Axelrad Kathryn C. Chatfield Aaron Chidekel William Dobyns Daniel Doyle Bronwyn Kerr Angela E. Lin David D. Schwartz Barbara J. Sibbles Dawn Siegel Suma P. Shankar David A. Stevenson Mihir M. Thacker K. Nicole Weaver Sue M. White Katherine A. Rauen 《American journal of medical genetics. Part A》2019,179(9):1725-1744
Costello syndrome (CS) is a RASopathy caused by activating germline mutations in HRAS. Due to ubiquitous HRAS gene expression, CS affects multiple organ systems and individuals are predisposed to cancer. Individuals with CS may have distinctive craniofacial features, cardiac anomalies, growth and developmental delays, as well as dermatological, orthopedic, ocular, and neurological issues; however, considerable overlap with other RASopathies exists. Medical evaluation requires an understanding of the multifaceted phenotype. Subspecialists may have limited experience in caring for these individuals because of the rarity of CS. Furthermore, the phenotypic presentation may vary with the underlying genotype. These guidelines were developed by an interdisciplinary team of experts in order to encourage timely health care practices and provide medical management guidelines for the primary and specialty care provider, as well as for the families and affected individuals across their lifespan. These guidelines are based on expert opinion and do not represent evidence‐based guidelines due to the lack of data for this rare condition. 相似文献
56.
Martineau M Jalali GR Barber KE Broadfield ZJ Cheung KL Lilleyman J Moorman AV Richards S Robinson HM Ross F Harrison CJ 《Genes, chromosomes & cancer》2005,43(1):54-71
This study was undertaken in order to compare the interphase and metaphase cytogenetics of 28 patients with ETV6/RUNX1 positive acute lymphoblastic leukemia, at diagnosis and relapse. The median time to relapse was 26 months. The significant fusion positive population heterogeneity revealed at interphase by a commercial probe for ETV6/RUNX1 fusion has not been described before. Six diagnostic samples had a single abnormal population; others had up to five each, which differed in the numbers of RUNX1 signals, and in the retention or loss of the second ETV6 signal. In contrast, the number of fusion signals was more constant. At relapse, there were fewer populations; the largest or unique clone was sometimes a re-emergence of a minor, diagnostic one, with a retained copy of ETV6 and the most RUNX1 signals. Abnormal, fusion negative clones were identified in bone marrow samples at extra-medullary relapse. Variant three or four-way translocations, which involved chromosomes 12 and 21, were prominent among the complex rearrangements revealed by metaphase FISH. The frequency of their occurrence at diagnosis and reappearance at relapse, sometimes accompanied by minor clonal evolution, was another new observation. Other recurrent cytogenetic features included a second copy of the fusion signal in six cases, partial duplication of the long arm of the X chromosome in two cases, and trisomy 10 in three cases. In comparing our data with previously reported cases, a picture is beginning to emerge of certain diagnostic features, which may provide circumstantial evidence of an increased risk of relapse. 相似文献
57.
Margaret?Holmes-RovnerEmail author Sue?Stableford Angela?Fagerlin John?T?Wei Rodney?L?Dunn Janet?Ohene-Frempong Karen?Kelly-Blake David?R?Rovner 《BMC medical informatics and decision making》2005,5(1):16
Background
Decision aids (DA) to assist patients in evaluating treatment options and sharing in decision making have proliferated in recent years. Most require high literacy and do not use plain language principles. We describe one of the first attempts to design a decision aid using principles from reading research and document design. The plain language DA prototype addressed treatment decisions for localized prostate cancer. Evaluation assessed impact on knowledge, decisions, and discussions with doctors in men newly diagnosed with prostate cancer. 相似文献58.
The pre-B cell receptor (preBCR) plays critical roles in early B cell differentiation. It has been shown that not all muH chains are capable of pairing with surrogate light (SL) chains to form preBCR. Here, we established a novel system to differentially identify two types of early pre-B cell populations in bone marrow and fetal liver of mice, one producing SL-pairing muH chains and the other producing SL-non-pairing muH chains. The former population accounted for 80% of all the early pre-B cells in adult bone marrow, while it accounted for only 20% of those in fetal liver. Comparison of the two types of pre-B cell populations in fetal liver revealed the structural difference between SL-pairing and -non-pairing muH chains encoded by the V(H)81X segment that was most frequently utilized in fetal liver pre-B cells but rarely expressed by B cells generated in adults. PreBCR played an important role in the positive selection of V(H)81X-muH chains carrying the characteristic sequences of the complementarity-determining region 3 with little or no nibbling or N nucleotide addition, leading to their predominance in neonatal splenic B cells. These fetal-type V(H)81X-muH chains were also detected in adult spleen, but almost exclusively in marginal zone (MZ) B cells in contrast to the adult-type V(H)81X-muH chains. This strongly suggests that neonatally generated and selected B cells expressing the stereotyped V(H)81X-muH chains are maintained in the adult MZ and could function as innate-like lymphocytes. 相似文献
59.
Daniel L. Hamilos MD John J. Oppenheimer MD Harold S. Nelson MD Sally Wenzel MD Sue Driscoll RN Richard F. Lockey MD David B. K. Golden MD Leland Fan MD Ralph J. Sanks RPh S. Allen Bock MD John W. Yunginger MD Donald Stevenson MD Timothy Sullivan MD Thomas Corbridge MD 《The Journal of allergy and clinical immunology》1993,91(6)
These guidelines are intended to reduce the potential for serious or life-threatening reactions when clinical research is conducted. The following issues were addressed: identifying the risks involved in the research, providing adequate safeguards in the protocol design and during withholding of medication, anticipating risks, minimizing the chances for human error, providing resuscitative equipment sufficient to deal with the most serious anticipated life-threatening reactions, planning for medical support in case of a life-threatening emergency, and optimizing the use of medical personnel and expertise to handle emergency situations. The guidelines also discuss important general issues about protocol design and implementation and the human subject consent form, which should facilitate the approval of protocols by the governing institutional review board.The guidelines are not meant to be inflexible or applicable to all research situations. However, it is our hope that they will allow for clinical research to be conducted in a manner that affords the research subjects a high degree of protection from unnecessary and possibly fatal injuries. 相似文献
60.
Transcriptional regulation of HLA class-II genes 总被引:5,自引:0,他引:5